Sa1730 - Treatment Discontinuation, Flares, and Hospitalizations Among Biologic-Naïve Patients with Inflammatory Bowel Disease over the first Year of Treatment: A Comparative Effectiveness Study of Vedolizumab Versus Infliximab

Bowel Disease ◽

First Year ◽

Effectiveness Study ◽

Comparative Effectiveness Study ◽

Inflammatory Bowel

P199 TREATMENT DISCONTINUATION, FLARES, AND HOSPITALIZATIONS AMONG BIOLOGIC-NAïVE PATIENTS WITH IBD OVER THE FIRST YEAR OF TREATMENT: A “REAL-WORLD” COMPARATIVE EFFECTIVENESS STUDY OF VEDOLIZUMAB VERSUS INFLIXIMAB

Gastroenterology ◽

10.1053/j.gastro.2017.11.259 ◽

2018 ◽

Vol 154 (1) ◽

pp. S111

Author(s):

Haridarshan Patel ◽

Mireia Raluy-Callado ◽

Ariel Berger ◽

Rebecca Curtis ◽

Javaria Mona Khalid

Keyword(s):

Real World ◽

First Year ◽

Effectiveness Study ◽

Comparative Effectiveness Study

P199 TREATMENT DISCONTINUATION, FLARES, AND HOSPITALIZATIONS AMONG BIOLOGIC-NAïVE PATIENTS WITH IBD OVER THE FIRST YEAR OF TREATMENT: A “REAL-WORLD” COMPARATIVE EFFECTIVENESS STUDY OF VEDOLIZUMAB VERSUS INFLIXIMAB

Inflammatory Bowel Diseases ◽

10.1093/ibd/izy038.038 ◽

2018 ◽

Vol 24 (suppl_1) ◽

pp. S78-S79

Author(s):

Haridarshan Patel ◽

Mireia Raluy-Callado ◽

Ariel Berger ◽

Rebecca Curtis ◽

Javaria Mona Khalid

Keyword(s):

Real World ◽

First Year ◽

Effectiveness Study ◽

Comparative Effectiveness Study

DOP067 Treatment discontinuation, flares and hospitalisations among biologic-naïve patients with IBD over the first year of treatment: a comparative effectiveness study of vedolizumab vs. infliximab

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.104 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S076-S076

Author(s):

M Raluy-Callado ◽

A Berger ◽

J M Khalid ◽

H Patel

Keyword(s):

First Year ◽

Effectiveness Study ◽

Comparative Effectiveness Study

Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center

Gastroenterology Research ◽

10.14740/gr934w ◽

2018 ◽

Vol 11 (1) ◽

pp. 41-45 ◽

Cited By ~ 12

Author(s):

Chaitanya Allamneni ◽

Krishna Venkata ◽

Huifeng Yun ◽

Fenglong Xie ◽

Lindsey DeLoach ◽

...

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Real World ◽

Bowel Disease ◽

Inflammatory Bowel

P702 F-calprotectin use in inflammatory bowel disease is characterized by improved diagnostic accuracy, less patient harm and decreased costs, compared with conventional serological markers and colonoscopy. A cost-effectiveness study in Italy

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx002.826 ◽

2017 ◽

Vol 11 (suppl_1) ◽

pp. S440-S440

Author(s):

B. Mascialino ◽

A. Vora

Keyword(s):

Cost Effectiveness ◽

Diagnostic Accuracy ◽

Bowel Disease ◽

Effectiveness Study ◽

Serological Markers ◽

Patient Harm ◽

Inflammatory Bowel ◽

Cost Effectiveness Study

776 Accelerated Infliximab Infusion Protocol for Inflammatory Bowel Disease: A Safety and Cost-Effectiveness Study in an Asian Tertiary Center

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592640.29532.13 ◽

2019 ◽

Vol 114 (1) ◽

pp. S451-S452

Author(s):

Chong Teik Lim ◽

Wan Chee Ong ◽

Hang Hock Shim ◽

Elaine Chan ◽

Teong Guan Lim ◽

...

Keyword(s):

Cost Effectiveness ◽

Bowel Disease ◽

Effectiveness Study ◽

Infliximab Infusion ◽

Tertiary Center ◽

Inflammatory Bowel ◽

Infusion Protocol ◽

Cost Effectiveness Study

Comparative effectiveness research in inflammatory bowel disease

Inflammatory Bowel Diseases ◽

10.1002/ibd.21693 ◽

2011 ◽

Vol 17 (6) ◽

pp. E46-E47 ◽

Cited By ~ 1

Author(s):

Eoin Slattery ◽

Gavin C. Harewood

Keyword(s):

Comparative Effectiveness Research ◽

Bowel Disease ◽

Effectiveness Research ◽

Inflammatory Bowel

Comparative Effectiveness Analysis of Flares, Hospitalisations, and Corticosteroid Use Among Biologic Naïve Patients with Inflammatory Bowel Disease Within 12 Months of Initiation of Vedolizumab or Infliximab

Gastroenterology ◽

10.1016/s0016-5085(17)32130-3 ◽

2017 ◽

Vol 152 (5) ◽

pp. S595

Author(s):

Javaria M. Khalid ◽

Naufil Alam ◽

Mireia Raluy ◽

Betsey Gardstein ◽

Rebecca I. Curtis

Keyword(s):

Bowel Disease ◽

Comparative Effectiveness Analysis

Effectiveness Analysis ◽

Inflammatory Bowel ◽

Characteristics of Inflammatory Bowel Disease With Onset During the First Year of Life

Journal of Pediatric Gastroenterology and Nutrition ◽

10.1097/01.mpg.0000237938.12674.e3 ◽

2006 ◽

Vol 43 (5) ◽

pp. 603-609 ◽

Cited By ~ 81

Author(s):

Frank M Ruemmele ◽

Maurice G El Khoury ◽

Cécile Talbotec ◽

Chantal Maurage ◽

Jean-François Mougenot ◽

...

Keyword(s):

Bowel Disease ◽

First Year ◽

Inflammatory Bowel ◽

First Year Of Life

95 Antibiotic Prescriptions in the First Year of Life Increases the Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Analysis

Gastroenterology ◽

10.1016/s0016-5085(10)60078-9 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-17 ◽

Cited By ~ 1

Author(s):

Souradet Y. Shaw ◽

James Blanchard ◽

Charles N. Bernstein

Keyword(s):

Bowel Disease ◽

Population Based ◽

First Year ◽

Pediatric Inflammatory Bowel Disease ◽

Inflammatory Bowel ◽

First Year Of Life